In conclusion, inhibition of METTL3 in NSCLC cell lines downregulated CYP19A1 protein expression and E2 production and conversely resulted in an increase in CYP19A1 mRNA expression levels. Here, CYP19A1 is linked to non-small cell lung carcinoma.